Showing 1 - 10 of 5,580
This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...
Persistent link: https://www.econbiz.de/10014637112
Persistent link: https://www.econbiz.de/10012208081
Persistent link: https://www.econbiz.de/10013555007
We examine the effect of pharmaceutical patent protection on the speed of drug launch, price, and quantity in 60 … countries from 2000-2013. The World Trade Organization required its member countries to implement a minimum level of patent … potential static losses that result from reduced competition during the patent term. We take advantage of the fact that at the …
Persistent link: https://www.econbiz.de/10012457867
We examine the effect of pharmaceutical patent protection on the speed of drug launch, price, and quantity in 60 … countries from 2000-2013. The World Trade Organization required its member countries to implement a minimum level of patent … potential static losses that result from reduced competition during the patent term. We take advantage of the fact that at the …
Persistent link: https://www.econbiz.de/10013031206
Persistent link: https://www.econbiz.de/10011881466
Persistent link: https://www.econbiz.de/10011698033
Persistent link: https://www.econbiz.de/10010391799
South Africa’s most important imports. The free transit of generic medicines, unhindered by patent claims, is essential for … unacceptable, because it violates the very foundations of, or justifications for, patent law. As shown by the quotation above …
Persistent link: https://www.econbiz.de/10014128167